A jury awarded $5 million to a patient and his wife after it found
GEHealthcare did not adequately warn patients and doctors about the risk
of its imaging dye, Omniscan. It was the first case involving the dye
to go to trial
In a setback for GE Healthcare, a jury on Friday found that the comp...
read more